Evidence map›Paper›PMID 34094502›Full record

ArticleCatalysis science & technology2021

Self-sufficient asymmetric reduction of β-ketoesters catalysed by a novel and robust thermophilic alcohol dehydrogenase co-immobilised with NADH.

Alejandro H Orrego, Daniel Andrés-Sanz, Susana Velasco-Lozano, Mercedes Sanchez-Costa, José Berenguer, José M Guisan, Javier Rocha-Martin, Fernando López-Gallego

Open access · hybridAbstract read
In one paragraph

Article in Catalysis science & technology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Alejandro H OrregoDepartment of Biocatalysis, Institute of Catalysis and Petrochemistry (ICP), CSIC Campus UAM, Cantoblanco 28049 Madrid Spain jmguisan@icp.csic.es javirocha@icp.csic.es.ORCID https://orcid.org/0000-0003-4412-1579
Daniel Andrés-SanzHeterogeneous Biocatalysis Laboratory, Center for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA) Paseo de Miramón 182 Donostia San Sebastián Spain flopez@cicbiomagune.es.ORCID https://orcid.org/0000-0003-2606-5999
Susana Velasco-LozanoHeterogeneous Biocatalysis Laboratory, Center for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA) Paseo de Miramón 182 Donostia San Sebastián Spain flopez@cicbiomagune.es.
Mercedes Sanchez-CostaDepartment of Molecular Biology, Universidad Autónoma de Madrid, Center for Molecular Biology Severo-Ochoa (UAM-CSIC) Nicolás Cabrera 1 28049 Madrid Spain.
José BerenguerDepartment of Molecular Biology, Universidad Autónoma de Madrid, Center for Molecular Biology Severo-Ochoa (UAM-CSIC) Nicolás Cabrera 1 28049 Madrid Spain.
José M GuisanDepartment of Biocatalysis, Institute of Catalysis and Petrochemistry (ICP), CSIC Campus UAM, Cantoblanco 28049 Madrid Spain jmguisan@icp.csic.es javirocha@icp.csic.es.ORCID https://orcid.org/0000-0003-1627-6522
Javier Rocha-MartinDepartment of Biocatalysis, Institute of Catalysis and Petrochemistry (ICP), CSIC Campus UAM, Cantoblanco 28049 Madrid Spain jmguisan@icp.csic.es javirocha@icp.csic.es.ORCID https://orcid.org/0000-0002-7681-5439
Fernando López-GallegoHeterogeneous Biocatalysis Laboratory, Center for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA) Paseo de Miramón 182 Donostia San Sebastián Spain flopez@cicbiomagune.es.ORCID https://orcid.org/0000-0003-0031-1880
CIC biomaGUNE · ESInstituto de Catálisis y Petroleoquímica · ESCentro de Biología Molecular Severo Ochoa · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

β-Hydroxyesters are essential building blocks utilised by the pharmaceutical and food industries in the synthesis of functional products. Beyond the conventional production methods based on chemical catalysis or whole-cell synthesis, the asymmetric reduction of β-ketoesters with cell-free enzymes is gaining relevance. To this end, a novel thermophilic (

Identifiers

PMID34094502
PMCPMC8111925
OpenAlexW3136821162

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.